Sagitta Biotech
PrivateLast Round
VC Round
Apr 23, 2026
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Sagitta Biotech is a biotechnology company that develops active non-replicating virosome platforms for vaccines, targeted oncology immunotherapies, and gene therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sagitta Biotech Comparables
Compare Sagitta Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Oncovita | 83% | |
| Seagull BioSolutions | 80% | |
| Ziphius Vaccines | 77% |
Sagitta Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Apr 23, 2026 | ||||
| Seed | Jul 30, 2025 | ||||
| Accelerator | Dec 16, 2024 |
Sagitta Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Noshaq | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 12, 2026
Monthly visitors grew 69% MoM.
- Dec 9, 2025
Monthly visitors increased 126% MoM, reaching 3.1K.
Sagitta Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Sagitta Biotech's valuation, stock price, and market status.
Is Sagitta Biotech a public or private company?
Sagitta Biotech is a private company.
What is the current stock price of Sagitta Biotech?
Sagitta Biotech is a private company with no public stock price. No recent secondary market data is available.
How much is Sagitta Biotech worth (valuation)?
Valuation information for Sagitta Biotech is not publicly available.
Can I buy Sagitta Biotech stock?
Sagitta Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Sagitta Biotech's last funding round?
Sagitta Biotech's most recent funding round was VC Round on April 23, 2026.
Who are the main investors in Sagitta Biotech?
Key investors in Sagitta Biotech include Noshaq.
Will Sagitta Biotech IPO soon?
No public IPO plans have been announced for Sagitta Biotech.
How can I track Sagitta Biotech secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Sagitta Biotech's secondary market activity and sign up for updates.